WHEN: 11:00 a.m. EDT on Wednesday, May 15, 2013
LOCATION: Online, with free registration
MODERATOR: Frost & Sullivan Partner Reenita Das
SPEAKERS: Latin America Healthcare Leader Eduardo Golisano
South Asia and Middle East Healthcare Director Sandeep Sinha
China Healthcare Director Xuchao Glenn Hou
Advanced Medical Technologies Global Program Manager Siddharth Saha
Multinational firms have been exploring opportunities in emerging markets as a strategy to face the Western slowdown. However, after facing limited growth in these regions during 2012, the major drug and device manufacturers are obliged to reassess their strategies. Heavyweights of the drug business, including Pfizer Inc., Merck, Bristol-Myers Squibb, GlaxoSmithKline and Novartis, are discovering that conquering markets in countries such as Brazil, Russia, India and China is not as easy as originally assumed.
Attend this webinar to discover:
The briefing will benefit any senior manager in the corporate strategy or global marketing areas that focuses on emerging markets, as well as any healthcare company looking to explore BRIC countries.
“Our team of more than 40 healthcare analysts on the ground in these four countries amassed an array of best practices of what works and what does not, based on actual experiences working through the regionally-specific barriers and opportunities alike,” said Frost & Sullivan Partner Reenita Das, who will moderate this webinar. “These best practices provide excellent lessons learned in the trenches through hands-on experience, which will be very beneficial for any company currently in these markets or looking to enter in the future. Our analysts have blazed the path to come out on the other side each time, more knowledgeable of the most opportune passageway.”
For more information about Frost & Sullivan’s Healthcare practice, please visit: http://www.healthcare.frost.com.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Corporate Communications – Europe
P: +39.02.4851 6133